About Metoprolol Succinate API
Therapeutic CategoryCardiovascular

CAS Number
98418-47-4
API Technology
Synthetic
Dose Form
Oral Solid/Tablets
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, CEP Submitted, Brazil DMF, Canada DMF, China DMF
Mechanism of Action
Several possible mechanisms have been proposed:
- Competitive antagonism of catecholamine at peripheral (especially cardiac) adrenergic neuron sites, leading to decreased cardiac output;
- A central effect leading to reduced sympathetic outflow to the periphery; and
- Suppression of renin activity.
Indication
- Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.
- Angina Pectoris.
- Heart Failure - for the treatment of stable, symptomatic (NYHA Class II or III) heart failure of ischemic, hypertensive, or cardiomyopathic origin.